Academia Sinica team identifies potential COVID-19 inhibitors

Taiwan's Academia Sinica said Friday that it has screened out protease inhibitors of the COVID-19 coronavirus, which could eventually lead to the development of targeted drugs to stop the virus from replicating itself in patients' bodies.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)